Temple University Hospital is being investigated by CMS over its care of a homeless patient who diedDrug distribution giant Cencora is boosting its reach in medical specialtiesCalifornia biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia One year of inspections at Fox Chase Cancer Center: November 2024 - October 2025Drexel University signed a lease to consolidate medical college research in University CityChristianaCare and Virtua Health have ended merger talksWhy Philadelphia loses promising biotech firms to Boston, San Francisco, and San DiegoBancroft, a South Jersey provider of IDD services, hired Gregory Passanante as its next CEO One year of inspections at Doylestown Hospital: November 2024 - October 2025CHOP was Southeastern Pa.’s most profitable nonprofit health system in first quarter of fiscal 2026. Four systems lost money.
California biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia
California biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia
CHOP was Southeastern Pa.’s most profitable nonprofit health system in first quarter of fiscal 2026. Four systems lost money.
CHOP was Southeastern Pa.’s most profitable nonprofit health system in first quarter of fiscal 2026. Four systems lost money.
